Emily Eshleman, PhD
Assistant Professor, Pediatrics (Gastroenterology) and Microbiology & Immunology
Locations
- Microbiology & Immunology
- BSB B2230
Contact Information
Education
PhD, Immunology, University of Colorado School of Medicine
Research Areas of Interest
- Allergy and Immunology
- Asthma
- Colitis, Ulcerative
- Crohn Disease
- Dysbiosis
- epithelial-immune interactions
- Epithelial-microbiota interactions
- Inflammatory Bowel Diseases
- Intestinal Mucosa
- Microbiota
- tuft cells
- Type 2 immunity
Research Experience
- Allergy and Immunology
- immunology
- mucosal immunology
Research Interests
The intestinal microbiota play a key role in immune development and tissue homeostasis, and perturbations in microbial communities, particularly during early life, are associated with an increased risk of inflammatory and allergic diseases. Despite the profound influence of the microbiota on human health, the mechanisms by which microbial signals are sensed by the host to regulate immune function remain incompletely understood. The intestinal epithelium is uniquely positioned at the interface between the microbiota and the underlying immune system, serving as a critical mediator of host–microbe interactions. In the Eshleman Lab, we investigate how the microbiota regulate epithelial cell fate and function and how these epithelial processes shape immune homeostasis and susceptibility to inflammatory and allergic diseases. A major focus of our research is to understand how tuft cells, a specialized epithelial cell type, coordinate communication between the intestinal lumen and the immune system. Ultimately, our work aims to provide a mechanistic framework for understanding how epithelial cells sense microbial signals to control immune function in health and disease.
Publications
-
Tuft cells protect against intestinal inflammation through histone deacetylase 3.
(Eshleman EM, Rice T, Waddell A, Kumar S, Didriksen BJ, Engleman L, Vidyant S, Sayed M, Karns R, Lim HW, Denson LA, Alenghat T.) Mucosal Immunol. 2026 Aug;19(4):100356 PMID: 42242519 PMCID: PMC13485144 06/05/2026
-
Microbiota-derived inosine programs protective CD8+ T cell responses against influenza in newborns.
(Stevens J, Culberson E, Kinder J, Ramiriqui A, Gray J, Bonfield M, Shao TY, Al Gharaibeh F, Peterson L, Steinmeyer S, Eshleman EM, Negi S, Zacharias W, Pryhuber G, Paul O, Sengupta S, Alenghat T, Way SS, Deshmukh H.) Cell. 2025 Aug 07;188(16):4239-4256.e19 PMID: 40494345 PMCID: PMC12335363 06/11/2025
-
Epithelial regulation of microbiota-immune cell dynamics.
(Didriksen BJ, Eshleman EM, Alenghat T.) Mucosal Immunol. 2024 Apr;17(2):303-313 PMID: 38428738 PMCID: PMC11412483 03/02/2024
-
(Eshleman EM, Rice T, Potter C, Waddell A, Hashimoto-Hill S, Woo V, Field S, Engleman L, Lim HW, Schumacher MA, Frey MR, Denson LA, Finkelman FD, Alenghat T.) Immunity. 2024 Feb 13;57(2):319-332.e6 PMID: 38295798 PMCID: PMC10901458 02/01/2024
-
(Velez Lopez A, Waddell A, Antonacci S, Castillo D, Santucci N, Ollberding NJ, Eshleman EM, Denson LA, Alenghat T.) Neurogastroenterol Motil. 2023 Dec;35(12):e14681 PMID: 37736865 PMCID: PMC10841278 09/22/2023
-
Cleaving an epithelial path to food tolerance.
(Eshleman EM, Alenghat T.) Cell Res. 2023 Dec;33(12):896-897 PMID: 37491601 PMCID: PMC10709587 07/26/2023
-
Kruppel-like factor 2+ CD4 T cells avert microbiota-induced intestinal inflammation.
(Shao TY, Jiang TT, Stevens J, Russi AE, Troutman TD, Bernieh A, Pham G, Erickson JJ, Eshleman EM, Alenghat T, Jameson SC, Hogquist KA, Weaver CT, Haslam DB, Deshmukh H, Way SS.) Cell Rep. 2023 Nov 28;42(11):113323 PMID: 37889750 PMCID: PMC10822050 10/27/2023
-
(Overcast GR, Meibers HE, Eshleman EM, Saha I, Waggoner L, Patel KN, Jain VG, Haslam DB, Alenghat T, VanDussen KL, Pasare C.) J Exp Med. 2023 Jun 05;220(6) PMID: 36976181 PMCID: PMC10067527 03/29/2023
-
Intestinal epithelial HDAC3 and MHC class II coordinate microbiota-specific immunity.
(Eshleman EM, Shao TY, Woo V, Rice T, Engleman L, Didriksen BJ, Whitt J, Haslam DB, Way SS, Alenghat T.) J Clin Invest. 2023 Feb 15;133(4) PMID: 36602872 PMCID: PMC9927950 01/06/2023
-
(Fawad JA, Luzader DH, Hanson GF, Moutinho TJ Jr, McKinney CA, Mitchell PG, Brown-Steinke K, Kumar A, Park M, Lee S, Bolick DT, Medlock GL, Zhao JY, Rosselot AE, Chou CJ, Eshleman EM, Alenghat T, Hong CI, Papin JA, Moore SR.) Gastroenterology. 2022 Nov;163(5):1377-1390.e11 PMID: 35934064 PMCID: PMC11551968 08/08/2022
-
(Woo V, Eshleman EM, Hashimoto-Hill S, Whitt J, Wu SE, Engleman L, Rice T, Karns R, Qualls JE, Haslam DB, Vallance BA, Alenghat T.) Cell Host Microbe. 2021 Dec 08;29(12):1744-1756.e5 PMID: 34678170 PMCID: PMC8667605 10/23/2021
-
(Eshleman EM, Bortell N, McDermott DS, Crisler WJ, Lenz LL.) Curr Res Immunol. 2020 Dec;1:1-9 PMID: 34337387 PMCID: PMC8323841 08/03/2021